430.53USD-0.38%Mkt Cap: —P/E: —Last update: 2026-06-01
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instrument…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value68.00B USD
Revenue (TTM)3.46B USD
Gross Profit1.58B USD
Net Income (TTM)-8.60M USD
Revenue/Share22.76 USD
Last Price430.53 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.1K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA139.16
EV/Revenue19.66
P/S—
P/B27.10
EPS (TTM)—
EPS (Forward)—
52W Range
250.0099% of range432.81
52W High432.81 USD
52W Low250.00 USD
Profitability
Gross Margin45.91%
Oper. Margin6.18%
EBITDA Margin14.13%
Profit Margin-0.25%
ROE-0.35%
ROA-0.14%
Growth
Revenue Growth2.70%
Earnings Growth-81.80%
Cash Flow & Leverage
Operating CF134.10M USD
CapEx (TTM)120.20M USD
FCF Margin6.14%
FCF Yield—
Net Debt1.57B USD
Net Debt/EBITDA3.22
Balance Sheet
Debt/Equity0.83
Current Ratio1.55
Quick Ratio0.65
Book Value/Sh16.09 USD
Cash/Share0.8760 USD
Dividends
Fwd Div Rate11.64 USD
Trail. Div Rate0.2000 USD
Div. Yield2.91%
5Y Avg Yield—
Payout Ratio—
Ex-Div DateMay 15, 2026
Pay DateJun 1, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float103.57M
Insiders0.00%
Institutions103.86%
Short Interest
Short Ratio0.1d
Shares Short2.41K
Short (prev mo.)943
Technical
SMA 50309.19 (+39.2%)
SMA 200321.03 (+34.1%)
Beta1.12
S&P 52W Chg27.94%
Avg Vol (30d)32.16K
Avg Vol (10d)22.17K
Technical Indicators
RSI (14)82.6
MACD22.3339
MACD Signal14.1695
MACD Hist.+8.1644
BB Upper406.44 USD
BB Middle341.73 USD
BB Lower277.03 USD
BB Width37.87%
ATR (14)11.88 USD
Vol Ratio (20d)0.15x